706 followers
MiR-194-5p enhances the sensitivity of nonsmall-cell lung cancer to doxorubicin through targeted inhibition of hypoxia-inducible factor-1 https://t.co/hW1DpAMUSZ
MiR-194-5p enhances the sensitivity of nonsmall-cell lung cancer to doxorubicin through targeted inhibition of hypoxia-inducible factor-1 https://t.co/hW1DpAMUSZ
New article: MiR-194-5p enhances the sensitivity of nonsmall-cell lung cancer to doxorubicin through targeted inhibition of hypoxia-inducible factor-1 https://t.co/Jix3OqgxTX #lungcancer #oncology https://t.co/1baX9M5yN6